Citadel Advisors’s Innoviva INVA Stock Holding History

Citadel Advisors’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$429K	Sell	18,400 -13,000	-41%	-$280K	﹤0.01%	9670
2025 Q4	$628K	Buy	+31,400	New	+$613K	﹤0.01%	8469
2025 Q2	–	Sell	-2,300	Closed	-$41.7K	–	13753
2025 Q1	$41.7K	Sell	2,300 -9,200	-80%	-$165K	﹤0.01%	12502
2024 Q4	$200K	Sell	11,500 -1,100	-9%	-$21.1K	﹤0.01%	10468
2024 Q3	$243K	Sell	12,600 -7,400	-37%	-$136K	﹤0.01%	9743
2024 Q2	$328K	Buy	20,000 +12,800	+178%	+$199K	﹤0.01%	8959
2024 Q1	$110K	Buy	7,200 +3,800	+112%	+$59.7K	﹤0.01%	11225
2023 Q4	$54.5K	Sell	3,400 -14,900	-81%	-$208K	﹤0.01%	11690
2023 Q3	$238K	Sell	18,300 -1,300	-7%	-$16.9K	﹤0.01%	9591
2023 Q2	$250K	Buy	19,600 +13,600	+227%	+$170K	﹤0.01%	9411
2023 Q1	$67.5K	Sell	6,000 -100	-2%	-$1.21K	﹤0.01%	11787
2022 Q4	$80.8K	Sell	6,100 -69,200	-92%	-$910K	﹤0.01%	11521
2022 Q3	$874K	Sell	75,300 -12,700	-14%	-$174K	﹤0.01%	7286
2022 Q2	$1.3M	Buy	88,000 +4,500	+5%	+$73.7K	﹤0.01%	6431
2022 Q1	$1.62M	Buy	83,500 +55,700	+200%	+$995K	﹤0.01%	6565
2021 Q4	$480K	Sell	27,800 -15,300	-35%	-$261K	﹤0.01%	9791
2021 Q3	$720K	Buy	43,100 +33,000	+327%	+$494K	﹤0.01%	8994
2021 Q2	$135K	Sell	10,100 -4,500	-31%	-$56.3K	﹤0.01%	12616
2021 Q1	$174K	Sell	14,600 -1,600	-10%	-$19.3K	﹤0.01%	11878
2020 Q4	$201K	Sell	16,200 -5,700	-26%	-$61.5K	﹤0.01%	9724
2020 Q3	$229K	Sell	21,900 -17,500	-44%	-$222K	﹤0.01%	8596
2020 Q2	$551K	Buy	39,400 +16,100	+69%	+$219K	﹤0.01%	6903
2020 Q1	$274K	Buy	23,300 +8,000	+52%	+$106K	﹤0.01%	7491
2019 Q4	$217K	Buy	+15,300	New	+$188K	﹤0.01%	8057
2019 Q3	–	Sell	-25,300	Closed	-$368K	–	9460
2019 Q2	$368K	Buy	25,300 +9,500	+60%	+$135K	﹤0.01%	7276
2019 Q1	$222K	Sell	15,800 -85,800	-84%	-$1.39M	﹤0.01%	8067
2018 Q4	$1.77M	Buy	101,600 +33,700	+50%	+$547K	﹤0.01%	4334
2018 Q3	$1.03M	Buy	67,900 +41,100	+153%	+$592K	﹤0.01%	5479
2018 Q2	$370K	Buy	26,800 +15,300	+133%	+$229K	﹤0.01%	6866
2018 Q1	$192K	Sell	11,500 -10,100	-47%	-$156K	﹤0.01%	7381
2017 Q4	$307K	Buy	+21,600	New	+$288K	﹤0.01%	6424
2017 Q3	–	Sell	-17,000	Closed	-$218K	–	7752
2017 Q2	$218K	Sell	17,000 -300	-2%	-$3.76K	﹤0.01%	6429
2017 Q1	$239K	Buy	17,300 +4,400	+34%	+$51.8K	﹤0.01%	6234
2016 Q4	$138K	Buy	+12,900	New	+$135K	﹤0.01%	6545
2016 Q1	–	Sell	-18,600	Closed	-$196K	–	7333
2015 Q4	$196K	Sell	18,600 -11,200	-38%	-$103K	﹤0.01%	5831
2015 Q3	$214K	Sell	29,800 -16,600	-36%	-$226K	﹤0.01%	6058
2015 Q2	$838K	Buy	46,400 +17,800	+62%	+$306K	﹤0.01%	4214
2015 Q1	$450K	Sell	28,600 -28,600	-50%	-$433K	﹤0.01%	5055
2014 Q4	$809K	Buy	57,200 +4,900	+9%	+$73.6K	﹤0.01%	4033
2014 Q3	$894K	Buy	52,300 +40,600	+347%	+$933K	﹤0.01%	3842
2014 Q2	$348K	Sell	11,700 -36,327	-76%	-$871K	﹤0.01%	4849
2014 Q1	$1.2M	Sell	48,027 -10,672	-18%	-$312K	﹤0.01%	3213
2013 Q4	$1.69M	Buy	58,699 +35,120	+149%	+$1.03M	﹤0.01%	2714
2013 Q3	$777K	Sell	23,579 -12,658	-35%	-$394K	﹤0.01%	3356
2013 Q2	$1.13M	Buy	+36,237	New	+$972K	﹤0.01%	3064

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's INVA Position: Q1 2026 in Review

Citadel Advisors reduced its Innoviva (INVA) stake by 1.3% in Q1 2026, selling an estimated $48.2K and leaving 176,077 shares worth $4.1M. The position accounts for ﹤0.01% of the portfolio, ranked #4668.

Citadel Advisors first reported a position in INVA in Q2 2013 and has held it in 49 quarters since. The position peaked at $28.9M in Q2 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

Citadel Advisors held 176,077 shares of Innoviva worth $4.1M as of Q1 2026.
Citadel Advisors sold 2,237 Innoviva shares in Q1 2026, an estimated $48.2K.
Innoviva made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4668 holding.
Citadel Advisors first reported a position in Innoviva in Q2 2013 and has held it in 49 quarters since.
Citadel Advisors's Innoviva position peaked at $28.9M in Q2 2025.
286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.